Item
Magnesium Sulfate Anhydrous (20488)
Magnesium Sulfate Anhydrous Food Grade
Food Ingredient
Attributes
- Ingredient declaration
Locations
| Location name | Address |
|---|---|
| Tomita Pharmaceutical Co., Ltd. | 85-1, Maruyama, Akinokami, Seto-cho Naruto, 36 7710360 JPN |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| HACCP | Tomita Pharmaceutical Co., Ltd. | !Confidential Document - TRACEGAINS RESPONSE 022224.pdf | 9/17/2024 | 9/17/2027 |
| Shelf Life | Tomita Pharmaceutical Co., Ltd. | _Control COA 20488-50573 - Magnesium Sulfate Anhydrous ID 1889651.pdf | 3/10/2022 | 3/9/2025 |
| CoA Sample | Tomita Pharmaceutical Co., Ltd. | _Control COA 20488-50573 - Magnesium Sulfate Anhydrous ID 1889651.pdf | 3/22/2022 | 3/21/2024 |
| Ingredient Statement | Tomita Pharmaceutical Co., Ltd. | 20488 Composition D10-24 R10-24 (ID 3197797).pdf | 10/16/2024 | 10/16/2027 |
| HACCP Process Flow Diagram | Tomita Pharmaceutical Co., Ltd. | 20488 Flow Chart R10-24 (ID 3200274).pdf | 10/25/2024 | 10/25/2026 |
| Gluten | Tomita Pharmaceutical Co., Ltd. | 20488 Gluten D11-21 R11-21 (ID 2201541).pdf | 8/10/2023 | 8/9/2025 |
| GRAS/NDI/ODI Statement | Tomita Pharmaceutical Co., Ltd. | 20488 GRAS Status D11-21 R12-21 (ID 2201544).pdf | 10/16/2024 | 10/16/2027 |
| Irradiation Status Statement | Tomita Pharmaceutical Co., Ltd. | 20488 Irradiation R2-25 (ID 3349538).pdf | 3/19/2025 | 3/19/2027 |
| EtO Statement | Tomita Pharmaceutical Co., Ltd. | 20488 Irradiation; ETO D11-21 R12-21 (ID 2201548).pdf | 12/4/2023 | 12/3/2025 |
| Kosher | Tomita Pharmaceutical Co., Ltd. | 20488 Kosher Certificate R10-24 Exp 10-29-25 (ID 3211335).pdf | 10/30/2023 | 10/29/2025 |
| Label Sample | Tomita Pharmaceutical Co., Ltd. | 20488 Product Label R7-24 (ID 3096408).pdf | 1/16/2025 | 1/16/2026 |
| California Prop. 65 | Tomita Pharmaceutical Co., Ltd. | 20488 Prop 65 D10-24 R10-24 (ID 3197795).pdf | 10/16/2024 | 10/16/2026 |
| Safety Data Sheet (SDS) | Tomita Pharmaceutical Co., Ltd. | 20488 Safety Data Sheet (SDS) D11-21 R10-24 (ID 3200284).pdf | 10/18/2024 | 10/18/2027 |
| Sewage Statement | Tomita Pharmaceutical Co., Ltd. | 20488 Sewage Sludge D10-24 R10-24 (ID 3200285).pdf | 10/18/2024 | 10/18/2026 |
| Natural | Tomita Pharmaceutical Co., Ltd. | 20488 Source R1-24 (ID 2900023).pdf | 8/29/2024 | 8/29/2025 |
| Product Specification Sheet | Tomita Pharmaceutical Co., Ltd. | 20488 Specification Sheet R10-24 (ID 3201328).pdf | 1/3/2025 | 1/3/2028 |
| Vegan/Vegetarian Statement | Tomita Pharmaceutical Co., Ltd. | 20488 Vegan D1-23 R3-23 (ID 2551004).pdf | 10/2/2023 | 10/1/2025 |
| WADA/NSF/NFL Statement | Tomita Pharmaceutical Co., Ltd. | 20488 WADA D11-21 R12-21 ID 2201572.pdf | 11/22/2023 | 11/21/2025 |
| Halal | Tomita Pharmaceutical Co., Ltd. | 20488-50573 - Halal Extension Letter - Magnesium Sulfate Anhydrous Food Grade - Exp 05-14-25.pdf | 2/26/2025 | 2/26/2027 |
| Country of Origin | Tomita Pharmaceutical Co., Ltd. | Country of Origin.pdf | 9/12/2024 | 9/12/2027 |
| No Animal Ingredient Statement | Tomita Pharmaceutical Co., Ltd. | FCID Standard Ingredient Form D02-20.pdf | 11/30/2021 | 11/30/2022 |
| GMO | Tomita Pharmaceutical Co., Ltd. | GMO D10-17 R10-17.pdf | 4/21/2021 | 4/21/2023 |
| Lot Code | Tomita Pharmaceutical Co., Ltd. | Lot Definition R08-22.pdf | 9/12/2024 | 9/12/2027 |
| Nutrition | Tomita Pharmaceutical Co., Ltd. | Nutrition.pdf | 9/6/2024 | 9/6/2027 |
| HARPC Food Safety Plan (Item) | Tomita Pharmaceutical Co., Ltd. | Proprietary Statement - TRACEGAINS RESPONSE.pdf | 5/26/2020 | 5/26/2023 |
| Residual Statement | Tomita Pharmaceutical Co., Ltd. | Residual Solvent D11-21 R12-21.pdf | 4/21/2022 | 4/21/2023 |
